HyalMax

For the symptomatic treatment of osteoarthritis in the knee

HyalMax

  • Na-hyaluronate 30mg/2ml

Sterile, viscoelastic solution for intra-articular use indicated for the symptomatic treatment of osteoarthritis in the knee.

Composition:

It consists of linear chains of sodium hyaluronate, with a medium molecular weight of (2.4 x 106 Dalton), obtained from Streptococcus bacteria and purified by fermentation.

This molecular weight promotes strong binding to fibroblast receptors, activation of a large number of receptors and stimulation of endogenous biosynthesis of hyaluronic acid.

Method of use:

Hyalmax is applied to the affected joint once a week for three consecutive weeks.
Do not exceed one cycle of treatment for any single joint in a 6-month period.
The product is used exclusively as an intra-articular injection.

Hyaluronic acid

Hyaluronic acid is a typical glycosaminoglycan (GAG), the only one that exists free, not bound to proteins.

Sodium hyaluronate is made of disaccharide units consisting of sodium glucuronate and N-acetylglucosamine. It is present in all tissues, is highly biocompatible and forms the main component of synovial fluid, where it is found in high concentration.

Mechanism of action of sodium hyaluronate:
Viscosupplementation → enables lubrication and shock absorption
Visco-induction → Establishing joint homeostasis by inducing endogenous production of hyaluronic acid lasts a long time after the injection itself

The most important effects of sodium hyaluronate:

  • Lubricant effect
  • Anti-inflammatory effect
  • Analgesic effect
  • Chondroprotective effect
  • Endogenous synthesis of hyaluronic acid

Clinical studies have proven that the intra-articular application of sodium hyaluronate provides a reduction in the simultaneous use of analgesics by up to 50%, and postpones the need for surgical implantation of a prosthesis.

Instructions for use (pdf 3.91 MB)

Download

Write to us

11 + 6 =

Mosorska 9, 11000 Belgrade, Serbia

Vemax011 Pharma doo representative office Northern Macedonia - Dane Krapcev 13, Skopje

Vemax011 Pharma doo representative office Montenegro - Topliški put 1, Budva

Vemax011 Pharma doo representative office Bosnia and Hercegovina - Vlakovo 252, Sarajevo

+381 (0)69 801 47 87

office@vemaxpharma.rs

Vemax Pharma - your trusted regional partner on the road to health!